Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Torrent Pharmaceuticals Limited

The flagship company of Torrent group, Torrent Pharmaceuticals Limited, is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. To cater to new niche segments and sharpen its focus among customers, Torrent Pharma has six marketing divisions, each catering to defined therapeutic segment. A 2300 strong field force caters to around 2,00,000 doctors across the country, which makes it rank fifth in terms of market reach.
Torrent Pharma’s competitive advantage as a manufacturer stems from its world-class manufacturing facilities. Its manufacturing facilities at Indrad, Gujarat, comply with WHO, cGMP, MHRA and TGA norms and have received ISO 9001, ISO 14001 and OHSAS 18001 (Occupational Health and Safety Management System) and ISO/IEC- 17025 certifications.
With a view to cater to its growth requirements, Torrent Pharma commissioned a new formulations manufacturing facility at Baddi, Himachal Pradesh, in November 2005. The facility has a capacity to manufacture 3600 million tablets, 400 million capsules and 18 million Oral Liquid bottles, per annum and would cater to the domestic formulations requirement.


Contact Details:
Ashram Road
Ahmedabad
Gujarat
380 009
India
Tel:91 - (0)79 - 26585090/3060
Fax:91-(0)79-26582100
Email:tplplant@icenet.net
WWW:

www.torrentpharma.com/




Recent Publications by Torrent Pharmaceuticals Limited:

Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects.
BACKGROUND AND OBJECTIVE: Advanced glycation end-products (AGEs) have been...
23rd October, 2009
Torrent Research Centre, Torrent Pharmaceuticals Ltd, Gandhinagar, Clin Drug Investig. 2009;29(9):559-75. doi:
DOI Direct Link
Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor.
A novel class of N-substituted 4-hydrazino piperidine derivatives were...
1st August, 2009
Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Bioorg Med Chem Lett. 2009 Sep 1;19(17):5021-5. Epub 2009 Jul 12.
DOI Direct Link
TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes.
Advanced glycation end products (AGEs) contribute significantly to...
24th June, 2009
Torrent Research Centre, Torrent Pharmaceuticals Ltd, Dist. Gandhinagar, J Cardiovasc Pharmacol. 2009 Jul;54(1):72-81.
DOI Direct Link
Synthesis of spiro[chroman-2,4'-piperidin]-4-one derivatives as acetyl-CoA carboxylase inhibitors.
Various spiro[chroman-2,4'-piperidin]-4-one derivatives (38a-m and 43a-j)...
23rd December, 2008
Medicinal Chemistry, Torrent Research Centre, Torrent Pharmaceuticals Ltd, Bioorg Med Chem Lett. 2009 Feb 1;19(3):949-53. Epub 2008 Dec 3.
DOI Direct Link
Pharmaceutical GMP: past, present, and future--a review.
Good Manufacturing Practice (GMP) is a set of regulations, codes, and...
19th June, 2008
Torrent Pharmaceuticals Ltd, R & D Centre, Bhat, Gandhinagar, India. Pharmazie. 2008 Apr;63(4):251-5.

View more Torrent Pharmaceuticals Limited research publications.

BioNews Results for Torrent Pharmaceuticals Limited:

Torrent Pharma commissions new facility for Novo Nordisk
MyIris:  Nov 15 2009 2:35AM Matching: torrent pharmaceuticals
Torrent starts new insulin plant
NewKerala.com:  Nov 15 2009 2:31PM Matching: torrent pharmaceuticals
Torrent Pharmaceuticals
Moneycontrol.com:  Nov 15 2009 10:05PM Matching: torrent pharmaceuticals
Torrent Pharma begins new plant for Novo Nordisk
Stockwatch.in:  Nov 14 2009 10:32PM Matching: torrent pharmaceuticals
Torrent commissions insulin facility
NewKerala.com:  Nov 14 2009 1:59PM Matching: torrent pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Torrent Pharmaceuticals Limited news.

Torrent Pharmaceuticals Limited Patents:

US Patent No.Title
7223777 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof
7138416 Compounds and therapeutic uses thereof
6624178 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
6608094 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
6515132 Process for the preparation of rosiglitazone maleate

View more Torrent Pharmaceuticals Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 2741 times since April 2007, the link to the organisation's website has been followed 337 times

Recent Search Terms used to find this page: Good manufacturing practice video torrent | acetyl co-a carboxylase Torrent | Torrent Pharma news Oct 2009 | torrent pharma | torrent pharma | medicinal chemistry torrent | Torrent Pharmaceuticals | Torrent Pharmaceuticals Gujarat contact details | Torrent Pharmaceuticals Gujarat contact details | Torrent Pharmaceuticals Gujarat contact details | .

Search for more companies in Ahmedabad

Search for more companies in Gujarat



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Torrent Pharmaceuticals Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.